Related Experiment Videos
[Clinical study on bronchial asthma patients whose bronchial hypersensitivity has been improved]
A Kawasaki1, K Hoshino, Y Mizushima
1First Department of Internal Medicine, Toyama Medical and Pharmaceutical University.
Arerugi = [Allergy]
|August 1, 1990
Summary
Improving bronchial hypersensitivity in asthma patients is linked to higher FEV1.0% and maintaining a symptom-free state. These factors are crucial for better respiratory health outcomes in asthma management.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Clinical Medicine
Background:
- Asthma is a chronic respiratory disease characterized by bronchial hypersensitivity.
- Factors influencing the improvement of bronchial hypersensitivity require further investigation for effective asthma management.
Purpose of the Study:
- To identify key factors associated with the improvement of bronchial hypersensitivity in asthmatic patients.
- To explore the relationship between lung function, symptom duration, and bronchial hypersensitivity.
Main Methods:
- Clinical investigation of 42 asthmatic patients with repeated bronchial hypersensitivity testing.
- Comparison of demographic, clinical, and therapeutic data between improved and unimproved groups.
- Analysis of forced expiratory volume in 1 second (FEV1.0%) and histamine test improvement index.
Main Results:
- 16 out of 42 patients showed improvement in bronchial hypersensitivity.
- Higher FEV1.0% was significantly associated with improved bronchial hypersensitivity (p < 0.01).
- Symptom-free status was achieved in all improved cases (100%) versus 38% in the unimproved group.
- Extended symptom-free periods correlated with increased improvement in histamine tests.
Conclusions:
- Higher baseline FEV1.0% facilitates the improvement of bronchial hypersensitivity in asthma.
- Achieving and maintaining a symptom-free state is critical for resolving bronchial hypersensitivity.
- These findings underscore the importance of lung function and sustained remission in asthma care.